Inhibikase Therapeutics, Inc. (IKT) Current Reports & Earnings Releases
Upcoming
- 2026-11-13 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-26 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2026-08-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-29 | 8-K | Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2026-07-23 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-07-14 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-29 | 8-K | Officer / Director Changes, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-07 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-26 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-12-19 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-21 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-08-14 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-30 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-14 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-02-24 | 8-K | Material Agreement, Unregistered Sales, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-18 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-01-29 | 8-K | Other Events | SEC |
| 2025-01-06 | 8-K | Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-12-05 | 8-K | Termination of Agreement | SEC |
| 2024-10-22 | 8-K | Material Agreement, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-10-10 | 8-K | Material Agreement, Unregistered Sales, Officer / Director Changes, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-10-09 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-06 | 8-K | Shareholder Vote Results | SEC |
| 2024-06-10 | 8-K | Shareholder Vote Results | SEC |
| 2024-05-20 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-04-30 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-04-19 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-02-07 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-01 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-01-16 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.